Filter
6926
Filtered Results: 6926
Text search:
health
care
products
Featured
Recommendations
712
New Publications
1878
Language
Document type
No document type
3683
Studies & Reports
1149
Guidelines
990
Manuals
409
Strategic & Response Plan
277
Fact sheets
172
Training Material
125
Situation Updates
63
Infographics
21
Resource Platforms
18
Brochures
14
Online Courses
4
App
1
Countries / Regions
Global
301
India
278
Kenya
194
Sierra Leone
139
Ethiopia
137
South Africa
133
Nigeria
132
Western and Central Europe
127
Liberia
124
Nepal
116
Uganda
107
Latin America and the Carribbean
104
Myanmar / Burma
95
Malawi
94
Ghana
88
Rwanda
88
Africa
87
Tanzania
85
Ukraine
82
Zambia
81
Bangladesh
79
Syria
74
Philippines
64
Namibia
55
South–East Asia Region
52
Congo, Democratic Republic of
49
Zimbabwe
43
Eastern Europe
43
Haiti
41
Guinea
40
West and Central Africa
40
Asia
38
East and Southern Africa
36
Cambodia
35
Indonesia
35
Lesotho
35
Mozambique
34
South Sudan
33
Senegal
31
Eastern Europe and Central Asia
31
Russia
31
Middle East and North Africa
28
Burkina Faso
24
Eswatini/ Swaziland
24
Yemen
24
Pakistan
23
Venezuela
22
Brazil
20
Cameroon
19
Germany
19
Botswana
19
Sudan
17
USA
15
Afghanistan
15
Western Pacific Region
15
Jordan
14
Benin
13
Central African Republic
13
Moldova
13
Colombia
12
Vietnam
12
Mali
11
Lebanon
11
China
11
Madagascar
11
Côte d’Ivoire / Ivory Coast
10
Somalia
10
Thailand
10
Turkey
9
Albania
9
Tajikistan
9
Peru
8
Georgia
8
Iraq
7
North Macedonia
7
Ecuador
7
Iran
7
Argentina
6
Paraguay
6
Laos
6
Kyrgyzstan
6
North America
6
United Kingdom
6
Egypt
5
Chad
5
Papua New Guinea
5
Serbia
5
Sri Lanka
5
Bhutan
5
Poland
5
Southern Africa
5
Kazakhstan
5
Saudi Arabia
4
Chile
4
Palestine
4
Timor Leste/ East Timor
4
Romania
4
Japan
4
Spain
4
Guinea-Bissau
3
Ireland
3
Hungary
3
Croatia
3
Bolivia
3
Libya
3
Fiji
3
Uzbekistan
3
Turkmenistan
3
Mauritius
3
Tunisia
3
Portugal
3
Niger
2
Gambia
2
Singapore
2
Burundi
2
Angola
2
Guatemala
2
Mexico
2
North Korea
2
Armenia
2
Mongolia
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Jamaica
2
Azerbaijan
2
Bosnia and Herzegovina
2
Morocco
1
Togo
1
Malaysia
1
Mauritania
1
Vanuatu
1
Switzerland
1
Honduras
1
El Salvador
1
Greece
1
Other region
1
Solomon Islands
1
Djibouti
1
Congo-Brazzaville
1
Australia
1
Gabon
1
Denmark
1
France
1
Maldives
1
Algeria
1
Morocco
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2451
Clinical Guidelines
645
Public Health
424
Women & Child Health
423
Key Resources
349
Capacity Building
133
Pharmacy & Technologies
100
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
COVID-19
647
HIV
459
Mental Health
417
TB
339
Planetary Health
255
AMR
247
Disability
228
Rapid Response
225
Ebola
211
Caregiver
207
Pharmacy
201
Conflict
186
NTDs
172
NCDs
126
Global Health Education
123
Refugee
105
Natural Hazards
90
Health Financing Toolbox
77
Zika
57
Specific Hazards
54
Cholera
49
Polio
30
Social Ethics
26
Typhoon
4
Health Financing
1
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
27 May 2021
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public he... scenarios, recognizing that there is no one-size-fits-all approach to managing cases and outbreaks of COVID-19. Each country should assess its risk and rapidly implement the necessary measures at the appropriate scale to reduce both COVID-19 transmission and economic, public and social impacts.
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional ...
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarizes information about innovative new ... being developed and sets out the immediate research and development priorities.
WHO recommends replacing western blotting and line immunoassays with simpler tests in HIV testing services. These simpler tests include rapid diagnostic tests (RDTs) that can be used at the point-of-care, and enzyme immunoassays (EIAs).
These tes...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. Th...
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field
application rates of new molluscicide products for control of schistosomia...
Quick guide to video-supported treatment of tuberculosis (2020).
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million pe...
28 May 2021
Contact tracing is a key component of a public health response to infectious disease outbreaks. The purpose of this guidance is to reinforce the place of community engagement and participation in the contact tracing process. The guidanc...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
COVID-19, a disease caused by a novel corona virus (SARS CoV-2), is currently a pandemic, which produces high morbidity in the elderly and in patients with associated comorbidities. Chronic kidney disease stage-5 (CKD-5) patients on dialysis [mainte...
This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections:
Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Use...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical pr...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in distric...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio...
Updated 22 august 2016. This document aims to provide interim guidance on the case definition of GBS and strategies to manage the syndrome, in the context of Zika virus and its potential association with GBS. This document is intended to inform the development of local clinical protocols and ... policies related to the care of patients with GBS
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health...
